CJ
PFE icon

Caitlin John’s Pfizer PFE Stock Holding History

Caitlin John’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
19,323
+841
+5% +$22K 0.25% 98
2026
Q1 		$519K Buy
18,482
+945
+5% +$25.2K 0.31% 54
2025
Q4 		$437K Buy
17,537
+851
+5% +$21.5K 0.29% 80
2025
Q3 		$425K Buy
16,686
+4,208
+34% +$104K 0.3% 72
2025
Q2 		$302K Buy
+12,478
New +$291K 0.28% 96
2025
Q1 		– Sell
-3,788
Closed -$101K – 602
2024
Q4 		$101K Sell
3,788
-17,453
-82% -$473K 0.07% 174
2024
Q3 		$568K Sell
21,241
-762
-3% -$22.2K 0.35% 65
2024
Q2 		$616K Buy
22,003
+17,213
+359% +$474K 0.44% 58
2024
Q1 		$133K Buy
4,790
+1,751
+58% +$48.6K 0.1% 140
2023
Q4 		$87.5K Buy
+3,039
New +$91.9K 0.07% 151

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Caitlin John's PFE Position: Q2 2026 in Review

Caitlin John increased its Pfizer (PFE) stake by 4.6% in Q2 2026, buying an estimated $22K and bringing the position to 19,323 shares worth $465K. The position accounts for 0.25% of the portfolio, ranked #98.

Caitlin John first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $616K in Q2 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Caitlin John held 19,323 shares of Pfizer worth $465K as of Q2 2026.
  • Caitlin John bought 841 Pfizer shares in Q2 2026, an estimated $22K.
  • Pfizer made up 0.25% of Caitlin John's portfolio in Q2 2026, its #98 holding.
  • Caitlin John first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Caitlin John's Pfizer position peaked at $616K in Q2 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.